For patients with comorbid liver impairment (elevated ALT/AST ratio) or cognitive impairment (e.g., hepatic encephalopathy risk), a low aromatic amino acid dietary regimen may be preemptively designed to reduce pseudo-neurotransmitter accumulation. Here, GPT is linked to Cognitive impairment.